vs
DigitalOcean Holdings, Inc.（DOCN）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
DigitalOcean Holdings, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$242.4M vs $207.3M），DigitalOcean Holdings, Inc.净利率更高（10.6% vs -62.0%，领先72.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 18.3%），DigitalOcean Holdings, Inc.自由现金流更多（$31.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 14.5%）
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DOCN vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $242.4M | $207.3M |
| 净利润 | $25.7M | $-128.6M |
| 毛利率 | 58.7% | — |
| 营业利润率 | 16.0% | -54.7% |
| 净利率 | 10.6% | -62.0% |
| 营收同比 | 18.3% | 25.9% |
| 净利润同比 | 40.5% | 3.5% |
| 每股收益（稀释后） | $0.23 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $242.4M | $207.3M | ||
| Q3 25 | $229.6M | $159.9M | ||
| Q2 25 | $218.7M | $166.5M | ||
| Q1 25 | $210.7M | $139.3M | ||
| Q4 24 | $204.9M | $164.6M | ||
| Q3 24 | $198.5M | $139.5M | ||
| Q2 24 | $192.5M | $147.0M | ||
| Q1 24 | $184.7M | $108.8M |
| Q4 25 | $25.7M | $-128.6M | ||
| Q3 25 | $158.4M | $-180.4M | ||
| Q2 25 | $37.0M | $-115.0M | ||
| Q1 25 | $38.2M | $-151.1M | ||
| Q4 24 | $18.3M | $-133.2M | ||
| Q3 24 | $32.9M | $-133.5M | ||
| Q2 24 | $19.1M | $-131.6M | ||
| Q1 24 | $14.1M | $-170.7M |
| Q4 25 | 58.7% | — | ||
| Q3 25 | 59.6% | — | ||
| Q2 25 | 59.9% | — | ||
| Q1 25 | 61.4% | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 60.2% | — | ||
| Q2 24 | 61.0% | — | ||
| Q1 24 | 60.7% | — |
| Q4 25 | 16.0% | -54.7% | ||
| Q3 25 | 19.6% | -106.9% | ||
| Q2 25 | 16.3% | -64.8% | ||
| Q1 25 | 17.9% | -102.6% | ||
| Q4 24 | 15.9% | -74.3% | ||
| Q3 24 | 12.4% | -94.6% | ||
| Q2 24 | 11.6% | -79.1% | ||
| Q1 24 | 6.2% | -151.9% |
| Q4 25 | 10.6% | -62.0% | ||
| Q3 25 | 69.0% | -112.8% | ||
| Q2 25 | 16.9% | -69.0% | ||
| Q1 25 | 18.1% | -108.5% | ||
| Q4 24 | 8.9% | -80.9% | ||
| Q3 24 | 16.6% | -95.7% | ||
| Q2 24 | 9.9% | -89.5% | ||
| Q1 24 | 7.7% | -156.8% |
| Q4 25 | $0.23 | $-1.28 | ||
| Q3 25 | $1.51 | $-1.81 | ||
| Q2 25 | $0.39 | $-1.17 | ||
| Q1 25 | $0.39 | $-1.57 | ||
| Q4 24 | $0.21 | $-1.34 | ||
| Q3 24 | $0.33 | $-1.40 | ||
| Q2 24 | $0.20 | $-1.52 | ||
| Q1 24 | $0.15 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $254.5M | $421.0M |
| 总债务越低越好 | $1.3B | — |
| 股东权益账面价值 | $-28.7M | $-80.0M |
| 总资产 | $1.8B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $254.5M | $421.0M | ||
| Q3 25 | $236.6M | $202.5M | ||
| Q2 25 | $387.7M | $176.3M | ||
| Q1 25 | $360.4M | $127.1M | ||
| Q4 24 | $428.4M | $174.0M | ||
| Q3 24 | $439.9M | $150.6M | ||
| Q2 24 | $443.1M | $480.7M | ||
| Q1 24 | $419.1M | $112.3M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-28.7M | $-80.0M | ||
| Q3 25 | $-69.6M | $9.2M | ||
| Q2 25 | $-175.2M | $151.3M | ||
| Q1 25 | $-210.7M | $144.2M | ||
| Q4 24 | $-203.0M | $255.0M | ||
| Q3 24 | $-211.7M | $346.8M | ||
| Q2 24 | $-253.8M | $432.4M | ||
| Q1 24 | $-286.1M | $140.3M |
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.5B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $31.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 12.8% | -48.6% |
| 资本支出强度资本支出/营收 | 10.8% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.23× | — |
| 过去12个月自由现金流最近4个季度 | $180.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $57.3M | $-99.8M | ||
| Q3 25 | $95.8M | $-91.4M | ||
| Q2 25 | $92.4M | $-108.3M | ||
| Q1 25 | $64.1M | $-166.5M | ||
| Q4 24 | $71.3M | $-79.3M | ||
| Q3 24 | $73.4M | $-67.0M | ||
| Q2 24 | $71.3M | $-77.0M | ||
| Q1 24 | $66.7M | $-190.7M |
| Q4 25 | $31.1M | $-100.8M | ||
| Q3 25 | $88.0M | $-92.7M | ||
| Q2 25 | $59.3M | $-110.7M | ||
| Q1 25 | $2.1M | $-167.8M | ||
| Q4 24 | $26.1M | $-79.5M | ||
| Q3 24 | $16.0M | $-68.6M | ||
| Q2 24 | $39.5M | $-79.0M | ||
| Q1 24 | $23.0M | $-193.9M |
| Q4 25 | 12.8% | -48.6% | ||
| Q3 25 | 38.3% | -58.0% | ||
| Q2 25 | 27.1% | -66.5% | ||
| Q1 25 | 1.0% | -120.5% | ||
| Q4 24 | 12.7% | -48.3% | ||
| Q3 24 | 8.1% | -49.2% | ||
| Q2 24 | 20.5% | -53.7% | ||
| Q1 24 | 12.5% | -178.2% |
| Q4 25 | 10.8% | 0.5% | ||
| Q3 25 | 3.4% | 0.8% | ||
| Q2 25 | 15.2% | 1.5% | ||
| Q1 25 | 29.4% | 1.0% | ||
| Q4 24 | 22.1% | 0.1% | ||
| Q3 24 | 28.9% | 1.2% | ||
| Q2 24 | 16.6% | 1.4% | ||
| Q1 24 | 23.6% | 3.0% |
| Q4 25 | 2.23× | — | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 2.50× | — | ||
| Q1 25 | 1.68× | — | ||
| Q4 24 | 3.91× | — | ||
| Q3 24 | 2.23× | — | ||
| Q2 24 | 3.73× | — | ||
| Q1 24 | 4.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
